196 related articles for article (PubMed ID: 29213240)
1. Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study.
Lai SW; Liao KF; Lin CL; Lin HF
Front Pharmacol; 2017; 8():859. PubMed ID: 29213240
[No Abstract] [Full Text] [Related]
2. Tamoxifen Use Correlates with Increased Risk of the First Episode of Ischemic Cerebrovascular Disease in Older Women with Breast Cancer: A Case-Control Study in Taiwan.
Lai SW; Lin CL; Liao KF
Front Pharmacol; 2017; 8():742. PubMed ID: 29089895
[No Abstract] [Full Text] [Related]
3. Long-term effects of pioglitazone on first attack of ischemic cerebrovascular disease in older people with type 2 diabetes: A case-control study in Taiwan.
Lai SW; Lin HF; Lin CL; Liao KF
Medicine (Baltimore); 2016 Aug; 95(31):e4455. PubMed ID: 27495077
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study.
Chen YC; Chen TH; Sun CC; Chen JY; Chang SS; Yeung L; Tsai YW
Acta Diabetol; 2020 Oct; 57(10):1181-1192. PubMed ID: 32318876
[TBL] [Abstract][Full Text] [Related]
5. Use of dipeptidyl peptidase-4 inhibitors and the risk of arthralgia: Population-based cohort and nested case-control studies.
Wang CY; Fu SH; Yang RS; Hsiao FY
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):500-506. PubMed ID: 30724413
[TBL] [Abstract][Full Text] [Related]
6. Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors: a population-based nested case-control study.
Chou HC; Chen WW; Hsiao FY
Drug Saf; 2014 Jul; 37(7):521-8. PubMed ID: 24859164
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients.
Chang CC; Chen YT; Hsu CY; Su YW; Chiu CC; Leu HB; Huang PH; Chen JW; Lin SJ
Am J Med; 2017 Mar; 130(3):348-355. PubMed ID: 27884648
[TBL] [Abstract][Full Text] [Related]
8. Case-control study examining the association between allopurinol use and ischemic cerebrovascular disease.
Lai SW; Lin CL; Liao KF
J Investig Med; 2019 Jan; 67(1):48-51. PubMed ID: 30042112
[TBL] [Abstract][Full Text] [Related]
9. Association of Glucagon-Like Peptide-1 Receptor Agonist vs Dipeptidyl Peptidase-4 Inhibitor Use With Mortality Among Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease.
Chen JJ; Wu CY; Jenq CC; Lee TH; Tsai CY; Tu HT; Huang YT; Yen CL; Yen TH; Chen YC; Tian YC; Yang CW; Yang HY
JAMA Netw Open; 2022 Mar; 5(3):e221169. PubMed ID: 35254430
[TBL] [Abstract][Full Text] [Related]
10. Effects of DPP-4 inhibitors on cardiovascular outcomes in patients with type 2 diabetes and end-stage renal disease.
Chan SY; Ou SM; Chen YT; Shih CJ
Int J Cardiol; 2016 Sep; 218():170-175. PubMed ID: 27236110
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibitors attenuates osteoporosis in patients with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan.
Chang CH; Lu CH; Chung CH; Su SC; Kuo FC; Liu JS; Li PF; Huang CL; Chen KC; Ho LJ; Kuo CC; Chang CY; Lin MS; Liu YC; Chu NF; Lee CH; Hung YJ; Hsieh PS; Lin FH; Hsieh CH; Chien WC
J Chin Med Assoc; 2022 Jul; 85(7):747-753. PubMed ID: 35648138
[TBL] [Abstract][Full Text] [Related]
12. Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study.
Huang TL; Hsiao FY; Chiang CK; Shen LJ; Huang CF
PLoS One; 2019; 14(5):e0215248. PubMed ID: 31112536
[TBL] [Abstract][Full Text] [Related]
13. All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes.
Yen FS; Chiang JH; Hwu CM; Yen YH; Lin BJ; Wei JC; Hsu CC
BMC Endocr Disord; 2019 Jan; 19(1):3. PubMed ID: 30611254
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: A retrospective cohort study.
Chin HJ; Nam JH; Lee EK; Shin JY
Medicine (Baltimore); 2017 Jun; 96(25):e7213. PubMed ID: 28640111
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Outcomes of Dipeptidyl Peptidase-4 Inhibitors in Elderly Patients With Type 2 Diabetes: A Nationwide Study.
Shih CJ; Chen HT; Kuo SC; Ou SM; Chen YT
J Am Med Dir Assoc; 2016 Jan; 17(1):59-64. PubMed ID: 26612484
[TBL] [Abstract][Full Text] [Related]
16. DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus.
Pariente A; Labat V; Mansiaux Y; Salvo F; Bégaud B; Raschi E; Faillie JL; Létinier L; Bezin J
Drug Saf; 2020 Aug; 43(8):767-774. PubMed ID: 32306223
[TBL] [Abstract][Full Text] [Related]
17. Effect of dipeptidyl peptidase IV inhibitors, thiazolidinedione, and sulfonylurea on osteoporosis in patients with type 2 diabetes: population-based cohort study.
Yang BR; Cha SH; Lee KE; Kim JW; Lee J; Shin KH
Osteoporos Int; 2021 Sep; 32(9):1705-1712. PubMed ID: 33594487
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibitors reduce the incidence of first cardiovascular events in Japanese diabetic patients.
Soejima H; Ogawa H; Morimoto T; Okada S; Matsumoto C; Nakayama M; Masuda I; Jinnouchi H; Waki M; Saito Y;
Heart Vessels; 2023 Nov; 38(11):1371-1379. PubMed ID: 37522902
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl Peptidase 4 Inhibitors Decrease the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Infection and Type 2 Diabetes Mellitus: A Nationwide Study in Taiwan.
Hsu WH; Sue SP; Liang HL; Tseng CW; Lin HC; Wen WL; Lee MY
Front Public Health; 2021; 9():711723. PubMed ID: 34604157
[No Abstract] [Full Text] [Related]
20. The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction.
Wang MT; Lin SC; Tang PL; Hung WT; Cheng CC; Yang JS; Chang HT; Liu CP; Mar GY; Huang WC
Cardiovasc Diabetol; 2017 Jul; 16(1):89. PubMed ID: 28697774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
